SBIR-STTR Award

Genomics Screening for Antiangiogenesis Drugs
Award last edited on: 7/23/02

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$99,701
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
John P Fruehauf

Company Information

Oncotech Inc

15501 Red Hill Avenue
Tustin, CA 92780
   (714) 566-0420
   drugdevelopment@oncotech.com
   www.oncotech.com
Location: Single
Congr. District: 45
County: Orange

Phase I

Contract Number: 1R43CA097900-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2002
Phase I Amount
$99,701
There is no text on file for this abstract.

Thesaurus Terms:
angiogenesis inhibitor, drug /agent, genetic screening, microarray technology, technology /technique development DNA, antineoplastic, apoptosis, biological signal transduction, gene expression, growth factor receptor, neoplasm /cancer blood supply, neoplasm /cancer chemotherapy, neoplasm /cancer pharmacology, vascular endothelium clinical research, flow cytometry, human tissue, immunomagnetic separation

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----